UNICHEM LABORATORIES
Quarterly Results Analysis [Mar2025]
UNICHEM LABORATORIES Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹587 Cr | ₹533 Cr | ₹462 Cr | ₹446 Cr | ₹460 Cr | ₹466 Cr | ₹416 Cr | ₹423 Cr |
Expenses | ₹503 Cr | ₹448 Cr | ₹405 Cr | ₹403 Cr | ₹438 Cr | ₹435 Cr | ₹407 Cr | ₹395 Cr |
Operating Income | ₹84 Cr | ₹86 Cr | ₹58 Cr | ₹43 Cr | ₹22 Cr | ₹31 Cr | ₹9 Cr | ₹28 Cr |
Other Income | ₹9 Cr | ₹14 Cr | ₹9 Cr | ₹4 Cr | ₹6 Cr | ₹11 Cr | ₹6 Cr | ₹9 Cr |
Interest | ₹5 Cr | ₹7 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹6 Cr | ₹7 Cr | ₹6 Cr |
Depreciation | ₹30 Cr | ₹31 Cr | ₹29 Cr | ₹28 Cr | ₹31 Cr | ₹32 Cr | ₹29 Cr | ₹29 Cr |
Profit Before Tax | ₹58 Cr | ₹62 Cr | ₹33 Cr | ₹15 Cr | ₹-133 Cr | ₹73 Cr | ₹-22 Cr | ₹2 Cr |
Profit After Tax | ₹53 Cr | ₹58 Cr | ₹30 Cr | ₹9 Cr | ₹-137 Cr | ₹73 Cr | ₹-24 Cr | ₹-1 Cr |
EPS | ₹7.52 | ₹8.22 | ₹4.33 | ₹1.31 | ₹-19.42 | ₹10.40 | ₹-3.48 | ₹-0.09 |
Industry Peers & Returns | 1W | 1M | 1Y |
UNICHEM LABORATORIES | -1.7% | 4.1% | 9.1% |
SUN PHARMACEUTICAL INDUSTRIES | -4.3% | -3% | -0.7% |
DIVIS LABORATORIES | -3.3% | -7.4% | 34.1% |
CIPLA | -4.4% | -0.5% | 0.7% |
TORRENT PHARMACEUTICALS | 1.4% | 10.1% | 17.9% |
DR REDDYS LABORATORIES | -5.2% | -5.7% | -5.9% |
MANKIND PHARMA | 0.8% | 8.4% | 26.4% |
ZYDUS LIFESCIENCES | -3.1% | -5.1% | -22.2% |
LUPIN | -4.9% | -4.6% | 0.9% |
UNICHEM LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 10.15 % |
Y-o-Y | 27.76 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹587 Cr | 10.15 | |
Dec2024 | ₹533 Cr | 15.35 | |
Sep2024 | ₹462 Cr | 3.52 | |
Jun2024 | ₹446 Cr | -2.86 | |
Mar2024 | ₹460 Cr | -1.31 | |
Dec2023 | ₹466 Cr | 12.05 | |
Sep2023 | ₹416 Cr | -1.79 | |
Jun2023 | ₹423 Cr | - |
UNICHEM LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -2.13 % |
Y-o-Y | 286.96 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹84 Cr | -2.13 | |
Dec2024 | ₹86 Cr | 48.65 | |
Sep2024 | ₹58 Cr | 32.26 | |
Jun2024 | ₹43 Cr | 101.10 | |
Mar2024 | ₹22 Cr | -30.49 | |
Dec2023 | ₹31 Cr | 254.85 | |
Sep2023 | ₹9 Cr | -68.70 | |
Jun2023 | ₹28 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -11.16 % |
Y-o-Y | 202.55 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 14.25% | -11.16 | |
Dec2024 | 16.04% | 28.84 | |
Sep2024 | 12.45% | 27.82 | |
Jun2024 | 9.74% | 106.79 | |
Mar2024 | 4.71% | -29.49 | |
Dec2023 | 6.68% | 216.59 | |
Sep2023 | 2.11% | -68.13 | |
Jun2023 | 6.62% | - |
UNICHEM LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -8.44 % |
Y-o-Y | Positive |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹53 Cr | -8.44 | |
Dec2024 | ₹58 Cr | 89.73 | |
Sep2024 | ₹30 Cr | 229.44 | |
Jun2024 | ₹9 Cr | Positive | |
Mar2024 | ₹-137 Cr | Negative | |
Dec2023 | ₹73 Cr | Positive | |
Sep2023 | ₹-24 Cr | Negative | |
Jun2023 | ₹-1 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -16.87 % |
Y-o-Y | Positive |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 9.02 % | -16.87 | |
Dec2024 | 10.85 % | 64.39 | |
Sep2024 | 6.6 % | 218.84 | |
Jun2024 | 2.07 % | Positive | |
Mar2024 | -29.75 % | Negative | |
Dec2023 | 15.72 % | Positive | |
Sep2023 | -5.89 % | Negative | |
Jun2023 | -0.16 % | - |
UNICHEM LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -8.52 % |
Y-o-Y | Positive |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹7.52 | -8.52 | |
Dec2024 | ₹8.22 | 89.84 | |
Sep2024 | ₹4.33 | 230.53 | |
Jun2024 | ₹1.31 | Positive | |
Mar2024 | ₹-19.42 | Negative | |
Dec2023 | ₹10.4 | Positive | |
Sep2023 | ₹-3.48 | Negative | |
Jun2023 | ₹-0.09 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD